Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, and Advica Health, an innovative patient-navigation membership service, are pleased to announce the signing of a letter of intent  (the “LOI”), to negotiate, in good faith, an agreement whereby Cannvas will become the exclusive provider of cannabis information and education to the Advica Health membership.

“Health care and patient care are rapidly evolving in Canada and teaming up with Advica Health is a great opportunity to offer Cannvas.Me to a large and growing membership base,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “As more and more people seek health and wellness through membership-based programs, we can play an important role providing education around the benefits of medical cannabis. We have also found that health care professionals require access to the same high quality information as their patients. As such, Cannvas.Me is a perfect fit for Advica Health and we look forward to working together to deliver physician-backed cannabis information and educational programs to its advisors and membership.”


Advica Health offers members access to the best facilities at home or abroad and assists to obtain advice, treatment options and solutions to current health care situations in the most efficient manner possible. Each case is approached on an individualized basis, to help navigate the current healthcare system and collaboratively create an effective health plan with ongoing care management and support from nurse navigators. Advica is constantly bringing innovative healthcare solutions to its membership, with a strong focus on preventative health and wellness. By keeping health top-of-mind, Advica helps members focus on healthy living, which highly impacts overall productivity and quality of life.

Through widespread integration, medical professionals and patients will be able to access the Cannvas.Me education platform when and where necessary. With membership-based programs such as Advica Health, patients can be referred to the online portal. For patients visiting participating medical clinics or related facilities, Cannvas offers a low-cost, application-specific handheld device that provides access to the benefits of health and wellness through cannabis and information specific to their needs.

Access to trusted information is important for both the patient and the prescribing medical professional. Due to the lack of available information, medical professionals have been reluctant to prescribe cannabis in its many forms. Providing information at the source of treatment gives patients peace of mind by exploring all alternatives, and doctors confidence to write suitable prescriptions for specific ailments.

About Advica Health
Advica is dedicated to support Canadians who want to personalize their individual medical treatment. Advica acts as thoughtful advisors to assist patients to improve health and wellness.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: www.cannvasmedtech.com; Media Inquiries: media@cannvasmedtech.com; Investor Relations: ir@cannvasmedtech.com, 1-800-489-0116

Click here to connect with < name and ticker> for an Investor Presentation.

Source: www.newswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less